Celsion announces $8M at-the-market registered direct offering Celsion has received commitments from two institutional healthcare investors to purchase an aggregate of approximately $8M of the company's common stock in an at-the-market registered direct offering and a concurrent private placement of warrants to purchase common stock. The company has agreed to sell an aggregate of 3M shares of its common stock at a per share price of $2.675 in a registered direct offering. Additionally, in a concurrent private placement, the company agreed to issue to the investors warrants to purchase, for each share of common stock purchased in the registered direct offering, 0.65 share of common stock for a total of 1.95M shares of common stock. The warrants have an exercise price of $2.60 per share and will expire five years from the date of issuance. The closing of the registered direct offering and the concurrent private placement is expected on or about June 1. The estimated net proceeds to the company in the registered direct offering are expected to be approximately $7.3M. The company intends to use the net proceeds for general corporate purposes.